From: Change in exhaled nitric oxide during peanut challenge is related to severity of reaction
 | Tolerant (n = 15) | Clinical allergy (n = 21) | p-value |
---|---|---|---|
Age (years) | |||
 Median (min, max) | 10.2 (7.5, 17.2) | 11.4 (5.1, 16.5) | 0.9054 |
Gender (%) | |||
 Males | 12 (80) | 10 (48) | 0.0833 |
Previous peanut ingestion (%) | |||
 Total | 12 (80) | 16 (76) | > 0.9999 |
Previous adrenaline usage (%) | |||
 Total | 1 (7) | 0 (0) | 0.4167 |
Other food allergy (%) | |||
 Total | 2 (13) | 5 (24) | 0.6738 |
Household smokers (%) | |||
 Total | 3 (20) | 4 (19) | > 0.9999 |
Allergic rhinitis (%) | |||
 Total | 11 (73) | 15 (71) | > 0.9999 |
AR severity for those with AR-max = 4a | |||
 Median (min, max) | 1 (1, 4) | 2 (1, 4) | 0.6860 |
Eczema ever (%) | |||
 Total | 11 (73) | 18 (86) | 0.4178 |
Eczema active treatment (%) | |||
 Total | 3 (20) | 5 (24) | > 0.9999 |
SCORAD for those with visible eczema | |||
 Median (min, max) | 15.3 (10.7, 36.0) | 14.7 (6.0, 32.5) | 0.6429 |
Asthma ever (%) | |||
 Total | 8 (53) | 7 (33) | 0.3104 |
Current preventer (%) | |||
 Total | 4 (27) | 4 (19) | 0.6940 |
Current reliever (%) | |||
 Total | 6 (40) | 4 (19) | 0.2600 |
Exercise related wheeze or dry nocturnal cough (%)b | |||
 Total | 8 (53) | 8 (38) | 0.4996 |
Peanut SPT (mm) | |||
 Median (min, max) | 3.5 (0.0, 10.0) | 7.0 (4.0, 9.0) | 0.0001 |
Peanut sIgE (kU/L) | |||
 Median (min, max) | 0.50 (0.01, 26.80) | 3.20 (0.10, 92.00) | 0.0054 |
Ara h2 sIgE (kU/L) | |||
 Median (min, max) | 0.13 (0.00, 1.00) | 1.60 (0.08, 70.30) | 0.0002 |
FeNO (NIOX VEROc) (p.p.b) | |||
 Median (min, max) | 22 (5, 49) | 29 (5, 97) | 0.2662 |
Percent predicted FEV1d | |||
 Median (min, max) | 100 (86, 121) | 102 (72, 124) | 0.7910 |
Percent predicted FVCd | |||
 Median (min, max) | 104 (88, 128) | 100 (70, 119) | 0.4147 |
Percent predicted FEV1/FVCd | |||
 Median (min, max) | 95 (82, 114) | 102 (93, 111) | 0.0692 |